A device smaller than a quarter is giving heart patients a new lease on life. The Watchman device is implanted in the heart to prevent blood clots from forming without the need of blood thinners. This ...

A Central New York man is sharing his story after decades of heart issues, and how a small device is helping protect his life.

The Cottage Heart & Vascular Center’s structural heart team at Santa Barbara Cottage Hospital (SBCH) recently performed their 1,000th WATCHMAN device procedure, a minimally invasive solution for ...

MedStar Heart & Vascular Institute now offers patients with irregular heart rhythm a minimally invasive option to reduce the risk of stroke, as well as enable stopping long-term use of blood thinning ...

There are hundreds of people who will be around to celebrate 2024 thanks to a little-known device called the WATCHMAN. “I think we’re actually at 250 for the program and at least 20 more procedures ...

PHOENIX — Abrazo Arizona Heart Hospital in Phoenix last week became the first health center in the state to implant a new device designed to reduce stroke risk. The hospital, which is located on ...

(Updated) SAN FRANCISCO, California — Preliminary data from the PREVAIL study of the Watchman (AtriTech/Boston Scientific) device for the prevention of stroke and systemic embolism in patients with ...

ROCHESTER, MN – The PREVAIL study, a clinical trial evaluating the safety of the Watchman (Boston Scientific) left atrial appendage (LAA) closure device in the treatment of patients with nonvalvular ...

ZANESVILLE – Genesis HealthCare System’s Heart and Vascular team recently performed the 300th WATCHMAN Implant procedure. The WATCHMAN Implant is completed through a minimally invasive procedure and ...

Left atrial appendage (LAA) occlusion procedures are designed to reduce the risk of thromboembolism in patients who have non-valvular atrial fibrillation, but a study presented at the 2023 ...

LAKE CHARLES, La. (KPLC) - A big milestone happened over at CHRISTUS Ochsner St. Patrick Hospital this week. Their cardiology team announced they have implanted 500 Watchman devices for patients with ...

Boston Scientific Corporation BSX recently announced favorable three-year primary endpoint data from the OPTION global clinical trial for its WATCHMAN FLX Left Atrial Appendage Closure (“LAAC”) device ...